Statistics

Total Visits

Views
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 427

Total Visits per Month

September 2014 October 2014 November 2014 December 2014 January 2015 February 2015 March 2015
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 31 24 63 54 56 58 14

File Downloads

Views
4403[1].pdf 82

Top Country Views

Views
United States 215
Russia 80
Poland 25
Denmark 24
Canada 16
China 14
United Kingdom 7
Germany 6
France 3
Hong Kong 3

Top City Views

Views
Minneapolis 73
Spartanburg 58
Houston 31
Miami Beach 16
Toronto 14
Zhengzhou 6
Beijing 5
San Jose 5
Kansas City 3
Brighton 2